91¹ú²ú¾«Æ·

Patients with hemophilia (a blood clotting disorder) can develop inhibitors (also called antibodies) when they have an immune response to factor concentrates (the treatment for hemophilia). Treatment of inhibitors is one of the biggest challenges in hemophilia care because patients with inhibitors can face greater risk of bleeding and the technique to get rid of […]

The post appeared first on .

As many as 900,000 people in the United States develop blood clots annually, and clots are responsible for approximately 100,000 deaths each year. Research has shown that fewer than one in four people has any recognizable signs and symptoms of a blood clot, so understanding the risk for blood clots is an important factor in […]

The post appeared first on .

The post appeared first on .

Nearly 900,000 people are affected by blood clots each year, leading to approximately 100,000 blood clot-related deaths annually. Dangerous blood clots such as deep-vein thrombosis (DVT) often form in the veins of a person’s arm or leg. If a DVT is left untreated, the clot can break loose and travel to the lungs (pulmonary embolism […]

The post appeared first on .

Sickle cell disease (SCD) is the most common genetic disorder in the United States, with about 100,000 American who have the disease and another 2 million who carry the trait. As people live with SCD for years, management of this disease and healthy living are important components of care, particularly for the pediatric population. Read […]

The post appeared first on .

Bone marrow is the soft tissue inside the bones that makes blood-forming cells known as blood stem cells. These grow into red blood cells (carry oxygen throughout the body), white blood cells (help fight infections), or platelets (help control bleeding). Healthy marrow and blood cells are needed to live. When a disease such as cancer […]

The post appeared first on .

Chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) are cancers that affect the same lymphocytes, a type of white blood cell. CLL and SLL are essentially the same disease. This “Patient Education” tear sheet was produced in collaboration with the Lymphoma Research Foundation (LRF) (www.lymphoma.org). Patient Education: What is CLL?

The post appeared first on .

Acute myeloid leukemia (AML) is the most common acute leukemia in the United States, comprising 33 percent of all leukemias. The cancer progresses rapidly if not treated, making timely diagnosis an important goal. Recent diagnostic tests and treatment options such as stem cell transplantation are improving the remission and cure rates for some patients with […]

The post appeared first on .

Amyloidosis is a rare disease that occurs due to a buildup of protein in different vital organs throughout the body. The disease is often misdiagnosed and not well understood, so there is a growing need for education. Light chain amyloidosis is the most common type of amyloidosis. Read below for more information about the diagnosis […]

The post appeared first on .

Hematopoietic cell transplantation (HCT), also called stem cell or bone marrow transplantation, is a treatment option for patients with blood cancers such as leukemia, multiple myeloma, or lymphoma. Together with radiation therapy or chemotherapy, HCT is designed to increase the chance of eliminating the blood cancer and restore normal blood cell production. Read on to […]

The post appeared first on .